Welcome to PsychU!

Cognition

Cognitive impairment is a key feature which is present across a variety of mental health conditions and may have an impact on overall quality of life. In this section we provide resources to help with identification and management strategies surrounding cognition and mental health. Content is updated continually so be sure to check in often.

Featured Resources

In-Depth Review Of The Australian Guidelines For Mood Disorders: Part 1

In-Depth Review Of The Australian Guidelines For Mood Disorders: Part 1

Managing mood disorders is challenging across the world. Following on from a robust discussion on international perspectives of mood guidelines with Drs. Gin Mahli from Australia, Dr. Sagar Parikh from the US and Canada, and Dr. Roger McIntyre from Canada, find out more about how the recent 2020 Royal Australian…
Illinois Medicaid Expands Access To Long-Acting Injectable Medications

Illinois Medicaid Expands Access To Long-Acting Injectable Medications

Illinois Medicaid Expands Access To Long-Acting Injectable Medications Provisions included in the Illinois annual Medicaid omnibus legislation require the medical assistance program to separately reimburse for long-acting injectable antipsychotic (LAIA) medications for mental health or substance use disorder treatment in the hospital inpatient setting.1 According to the Illinois Health and…

Upcoming Events

Ask A Question About Cognition

Enter your question in the box below and click “Ask My Question” to submit your inquiry.

You must be logged in to ask a question in this section.

Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

The Neuropsychiatric Inventory: Development & Applications

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Learning Tracks